Potential action of androstenedione on the proliferation and apoptosis of stromal endometrial cells

Reproductive Biology and Endocrinology

Volumn 2, Issue , 2004, Pages

  Maliqueo, Manuel A ^a,b   Quezada, Susana ^a   Clementi, Marisa ^a   Bacallao, Ketty ^a   Anido, Mabel ^a   Johnson, Cecilia ^a   Vega, Margarita ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; DNA FRAGMENT; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLUORESCEIN ISOTHIOCYANATE; HYDROXYFLUTAMIDE; ISOPROTEIN; KI 67 ANTIGEN; LIPOCORTIN 5; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOMETRIUM; ENDOMETRIUM CELL; EPITHELIUM CELL; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERANDROGENISM; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; MENSTRUATION; NICK END LABELING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; STROMA CELL;

EID: 18144431771     PISSN: 14777827     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-2-81     Document Type: Article

References (38)

1. Zawadzky JK, Dunaif A: Diagnosis criteria: Towards a rational approach. In In Current Issues in Endocrinology and Metabolism Edited by: Hershmann JM. Boston: Blackwell Scientific Publications; 1992:377-384.
2. Nestler JE: Polycystic ovary syndrome: a disorder for a generalist. Fertil Steril 1998, 70:811-812.
3. Adams J, Polson DW, Franks S: Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ 1986, 293:355-359.
4. Coulam CB, Annegers JF, Kranz JS: Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983, 61: 403-407.
5. Segreti L: Endometrial hyperplasia and carcinoma in women with androgen excess disorders. In In Androgen excess disorders women Edited by: Azziz R, Nestler J, Dewailly D. Lippincott-Raven; 1997:667-672.
6. Balen A: Polycystic ovary syndrome and cancer. Hum Reprod Update 2001, 7:522-525.
7. Maliqueo M, Clementi M, Gabler F, Johnson MC, Sir-Petermann T, Palomino A, Vega M: Steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003, 80(Suppl 2):812-819.
8. Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA: Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 2002, 66:297-304.
9. Gregory CW, Wilson EM, Apparao KB, Lininger RA, Meyer WR, Kowalik A, Fritz MA, Lessey BA: Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab 2002, 87:2960-2966.
10. Legro RS: Polycystic ovary syndrome: the new millenium. Mol Cell Endocrinol 2002, 186:219-225.
11. Carmina E, Lobo RA: Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999, 84: 1897-1899.
12. Narukawa S, Kanzaki H, Inoue T, Imai K, Higuchi T, Hatayama H, Kariya M, Mori T: Androgens induce prolactin production by human endometrial stromal cells in vitro. J Clin Endocrinol Metab 1994, 78:165-168.
13. Iwai M, Kanzaki H, Fujimoto M, Kojima K, Hatayama H, Inoue T, Higuchi T, Nakayama H, Mori T, Fujita J: Regulation of sex steroid receptor gene expression by progesterone and testosterone in cultured human endometrial stromal cells. J Clin Endocrinol Metab 1995, 80:450-454.
14. Tuckerman EM, Okon MA, Li T, Laird SM: Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 2000, 74:771-779.
15. Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T: Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J Clin Endocrinol Metab 1999, 84:1737-1743.
16. Gustafsson JA: An update on estrogen receptors. Semin Perinatol 2000, 24:66-69.
17. Hengartner MO: The biochemistry of apoptosis. Nature 2000, 407:770-776.
18. Castro A, Johnson MC, Anido M, Cortinez A, Gabler F, Vega M: Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis. Fertil Steril 2002, 78:587-595.
19. Green DR: Apoptosis pathways: paper wraps stone blunts scissors. Cell 2000, 102:1-4.
20. Bonney RC, Scanlon MJ, Jones DL, Reed MJ, James VH: Adrenal androgen concentrations in endometrium and plasma during the menstrual cycle. J Endocrinol 1984, 101:181-188.
21. Suri NK: Steroid content in endometrial tissue. East Afr Med J 1997, 74:242-248.
22. Rose GL, Dowsett M, Mudge JE, White JO, Jeffcoate SL: The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro. Fertil Steril 1988, 49:224-228.
23. Johnson MC, Maliqueo M, Boric MA, Villavicencio A, Vantman D, Vega M: Differential in vitro actions of nitric oxide on human endometrial cell survival. Fertil Steril 2004, 81:176-184.
24. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB: Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 1997, 82:3509-3512.
25. Watson H, Franks S, Bonney RC: Regulation of epidermal growth factor receptor by androgens in human endometrial cells in culture. Hum Reprod 1998, 13:2585-2591.
26. Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Millar MR, Saunders PT: Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 2001, 86:1370-1378.
27. Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M: Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab 2001, 86:1379-1386.
28. Critchley HO, Tong S, Cameron ST, Drudy TA, Kelly RW, Baird DT: Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo. J Reprod Fertil 1999, 115:389-395.
29. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001, 61:2537-2541.
30. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA: A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001, 98:6330-6335.
31. Petterson K, Gustafsson JA: Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001, 63:165-192.
32. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P: Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004, 11:537-551.
33. Cheng J, Lee EJ, Madison LD, Lazennec G: Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 2004, 566: 169-172.
34. Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P, Lazennec G: Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res 2004, 64:5861-5869.
35. Lessey BA: Endometrial integrins and the establishment of uterine receptivity. Hum Reprod 1998, 13(Suppl 3):247-259.
36. Lapointe J, Fournier A, Richard V, Labrie C: Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells. Endocrinology 1999, 140:416-421.
37. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y, Honjo H: Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 1997, 57:514-519.
38. Gibson M: Reproductive health and polycystic ovary syndrome. Am J Med 1995, 98:67S-75S.